Spectral AI, Inc. MDAI

Company Overview

Spectral AI, Inc. (NASDAQ: MDAI) is a medical diagnostics and artificial intelligence company focused on developing predictive imaging technologies for wound care and burn assessment. The company operates primarily within the healthcare technology, medical imaging, and AI-enabled diagnostics industries. Its core platform, DeepView System, combines multispectral imaging with proprietary machine learning algorithms to assist clinicians in evaluating tissue viability and predicting wound healing outcomes. The company’s principal revenue drivers have historically included government-funded research and development contracts, particularly from U.S. defense and public health agencies, alongside commercialization efforts tied to its diagnostic imaging platform.

Spectral AI primarily serves hospitals, burn centers, military medical organizations, emergency care providers, and wound care specialists. The company positions itself at the intersection of AI-driven clinical decision support and non-invasive imaging, with a strategic emphasis on reducing diagnostic subjectivity in burn and wound assessment. Spectral AI traces its origins to research initiatives focused on optical imaging and predictive analytics for battlefield medicine and acute care applications. Over time, it evolved from a research-oriented organization into a publicly traded healthcare technology company following its business combination with a special purpose acquisition company in 2023.